Divalproex Sodium Tablet, Delayed Release
NDC 69452-433
Product Information
Divalproex Sodium is a ANDA-approved product labeled by Bionpharma Inc.. This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It is supplied as a white tablet, delayed release for oral administration. This product entry covers the primary NDC 69452-433 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
511
Code Structure Chart
Product Details
What is NDC 69452-433?
What are the uses of this product?
What are Active Ingredients of this product?
- DIVALPROEX SODIUM 125 mg/1 - A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DIVALPROEX SODIUM (UNII: 644VL95AO6)
- VALPROIC ACID (UNII: 614OI1Z5WI) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- STARCH, CORN (UNII: O8232NY3SJ)
- POVIDONE K29/32 (UNII: 390RMW2PEQ)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A (UNII: NX76LV5T8J)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- TALC (UNII: 7SEV7J4R1U)
- HYPROMELLOSE 2910 (50 MPA.S) (UNII: 1IVH67816N)
- POLYETHYLENE GLYCOL 6000 (UNII: 30IQX730WE)
- SHELLAC (UNII: 46N107B71O)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- BUTYL ALCOHOL (UNII: 8PJ61P6TS3)
- ALCOHOL (UNII: 3K9958V90M)
- AMMONIA (UNII: 5138Q19F1X)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1099625 - divalproex sodium 125 MG Delayed Release Oral Tablet
- RxCUI: 1099678 - divalproex sodium 250 MG Delayed Release Oral Tablet
- RxCUI: 1099870 - divalproex sodium 500 MG Delayed Release Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Valproic Acid
Valproic acid is used alone or with other medications to treat certain types of seizures. Valproic acid is also used to treat mania (episodes of frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). It is also used to prevent migraine headaches but not to relieve headaches that have already begun. Valproic acid is in a class of medications called anticonvulsants. It works by increasing the amount of a certain natural substance in the brain.
[Learn More]
* Please review the full disclaimer at the bottom of this page.